Dapaclan 5 Tablet
Marketer
Meraki Health
Salt Composition
Dapagliflozin (5mg)
Overview Dapaclan 5 Tablet
Metformin 5mg tablets are indicated, either monotherapy or in conjunction with other therapies, for the management of type 2 diabetes. Its primary action is to regulate elevated blood glucose, thereby mitigating the risk of severe diabetic complications and cardiovascular events. This medication may be administered with or without food, consistently at the same time each day, as prescribed by your physician. Discontinuation should only occur under medical supervision; abrupt cessation can lead to hyperglycemia and potentially serious sequelae such as nephropathy and retinopathy. This medication forms one component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, all guided by professional medical advice. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Significant diuresis is possible; adequate hydration is crucial to prevent dehydration. Practicing good hygiene can reduce the likelihood of genital fungal infections. Prior to commencing therapy, patients should disclose any pre-existing renal or hepatic impairment, urinary tract infections, or diuretic use to their doctor. Pregnant or lactating individuals require medical consultation before initiating treatment. Excessive alcohol consumption should be avoided due to a potential increase in adverse reactions. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapaclan 5 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Dapaclan 5 Tablet
Managing type 2 diabetes
Major Benefits of Dapaclan 5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaclan 5 Tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dapaclan 5 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaclan 5 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaclan 5 Tablet can be consumed with or without food, although consistent timing is recommended.
How Dapaclan 5 Tablet works:
Dapaclan 5 tablets help manage blood sugar levels. This medication achieves this effect by facilitating the excretion of excess glucose via the urine.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Dapaclan 5 Tablet.
PregnancyCONSULT YOUR DOCTOR
Using Dapaclan 5 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapaclan 5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Dapaclan 5 Tablet due to potential safety concerns. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
Dapaclan 5 mg tablets can be administered to patients with hepatic impairment without modification of the prescribed dosage.
What if you forget to take Dapaclan 5 Tablet :
Should you forget a Dapaclan 5 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapaclan 5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |




